Professor Jenny Gunton is the Director of the Centre for Diabetes and Obesity Research at the Westmead Institute for Medical Research.
Jenny received her PhD from the University of Sydney and completed her post-doctoral fellowship in Ron Kahn’s lab at the Joslin Diabetes Center and Harvard Medical School. She returned to Australia to the Garvan Institute and set up the Diabetes and Transcription Factors lab. In 2014 she became Chair of Medicine at Sydney University, Westmead Hospital.
The studies on ARNT / HIF-1α, published in Cell and JCI have led to identification of a new therapeutic for the treatment of type 2 diabetes and obesity to improve human islet transplants which is being used in patients at the National Pancreas Transplant Unit, Sydney.
Abstracts this author is presenting: